Be prepared for the future

The field of allergy and autoimmunity disease management is constantly evolving. With an increasing prevalence the need for accurate diagnoses in a cost and time-efficient manner is growing. We can help you meet the needs from the clinicians – today and tomorrow.

The ImmunoCAP test portfolio covers more than 650 standardized, high-quality allergens for sensitive and specific quantitative detection of allergen-specific IgE antibodies.

To furthermore help clinicians to better diagnose and manage allergy patients the unique Molecular Allergology menu contains 90 ImmunoCAP components for measuring of individual proteins.

Molecular Allergology is the most exciting development to take place during my 40 years of allergy practice”
M. Wickman, M.Dr, Professor, ISMA Meeting 2010

The broad EliA portfolio grasps autoimmunity markers for evaluation of the most important autoimmune diseases such as rheumatoid arthritis, celiac disease, inflammatory bowel diseases, connective tissue diseases, anti-phospholipid syndrome and vasculitis.

“The EliA CTD Screen is highly suited to routine ANA screening, offering excellent sensitivity and specificity for clinically relevant ANAs.”
Wood G. Pathology in Practice 2010; 2-3

Continuous product development to ensure your competitiveness

Now more than ever, cost effective laboratory testing is highly demanded. Therefore, Phadia Laboratory Systems constantly will benefit from a continuous product development within areas such as information technology and bioinformatics.

As an active member of the international scientific and clinical communities, we continually share and contribute to the advancement of knowledge. Sharing this knowledge with our customers is one of our top priorities.


As in all diagnostic testing, the diagnosis is made by the physican based on both test results and the patient history.